Uniphyl and Hyperthyroid - a phase IV clinical study of FDA data

Summary:

Hyperthyroid is reported as a side effect among people who take Uniphyl (theophylline), especially for people who are female, 60+ old, also take Cardizem Cd, and have Asthma.

The phase IV clinical study analyzes which people have Hyperthyroid when taking Uniphyl. It is created by eHealthMe based on reports of 3,071 people who have side effects when taking Uniphyl from the FDA, and is updated regularly.

What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,109 drugs and 1,420 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

On Jun, 23, 2026

3,071 people reported to have side effects when taking Uniphyl.
Among them, 22 people (0.72%) have Hyperthyroid.

Among these 22 people:

What is the gender of people who have Hyperthyroid when taking Uniphyl? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperthyroid when taking Uniphyl? *

What are other drugs people take besides Uniphyl? *

What are other side effects people have besides Hyperthyroid? *

Sleep Disorder: 21 people, 95.45%
Wheezing (a high-pitched whistling sound made while you breath): 20 people, 90.91%
Weakness: 20 people, 90.91%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 20 people, 90.91%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 20 people, 90.91%
Cardiac Failure: 20 people, 90.91%
Chest X-Ray Abnormal: 20 people, 90.91%
Cholangitis (infection of the bile duct): 20 people, 90.91%
Choledocholithiasis (stones in the common bile duct): 20 people, 90.91%
Chronic Kidney Disease: 20 people, 90.91%

What are the existing conditions these people have? *

Asthma: 21 people, 95.45%
Sense Of Oppression (sense of heavy burden): 10 people, 45.45%
Pain: 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Uniphyl and have Hyperthyroid?

- Check whether Hyperthyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uniphyl:

Uniphyl (3,086 reports)

Hyperthyroid treatments and more:

Hyperthyroid (26,832 reports)

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroid:

Hyperthyroid (1,109 drugs)

Browse all the conditions that are associated with Hyperthyroid:

Hyperthyroid (1,420 conditions)

Related publications that referenced our studies

Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on theophylline (the active ingredients of Uniphyl) and Uniphyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.